DevPro Biopharma and Bespak have announced the completion of early feasibility studies on DP007, a new formulation of albuterol in a pressurized metered dose inhaler (pMDI) which shows comparable ...
DevPro Biopharma, Bespak complete early feasibility studies for new groundbreaking albuterol inhaler
DevPro Biopharma and Bespak have announced the completion of early feasibility studies on DP007, a new formulation of albuterol in a pressurized metered dose inhaler (pMDI) which shows comparable ...
Co-founder & CTO at WaveMaker. He brings two decades of experience in product design, innovation and technology. Over the last few years, witnessing the low-code evolution firsthand, Deepak worked ...
The Chronic Obstructive Pulmonary Disease Foundation and DevPro Biopharma have established a partnership to develop new therapies for people with chronic obstructive pulmonary disease (COPD) and other ...
Miami, FL, and Basking Ridge, NJ , March 23, 2021 (GLOBE NEWSWIRE) -- The Chronic Obstructive Pulmonary Disease Foundation and DevPro Biopharma LLC, a clinical research and development company, ...
Nearly 20 years ago I became the part-owner of a small IT firm in Erie, PA. We had two sides of the house — a networking and general IT group that installed networks, PCs, and handled desktop support ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results